RobertsSHayRJMackenzieDWRA clinician's guide to fungal disease. New York: Marcel Dekker, Inc., 1984: 18.
8.
Al DooryY. The epidemiology of cryptococcosis. In: GordonMA, ed., The epidemiology of human mycotic disease. Springfield, Ill.: Charles C. Thomas, 1975: 142–51.
9.
HirschEFColemanGH. Acute miliary torulosis of lungs. JAMA1929;92:437–8.
10.
CoxLBTolhurstJC. Human torulosis: a clinical, pathological, and microbiological study with a report of 13 cases. Melbourne, Australia: Melbourne University Press, 1946: 149.
11.
HaysRJ. Clinical manifestations and management of cryptococcosis in the compromised patients. In: WarnockDWRichardsonMD, eds., Fungal infection in the compromised patient. New York: John Wiley & Sons, 1982: 93–117.
12.
SpikardA. Diagnosis and treatment of cryptococcal disease. Southern Med J1973;66:26–31.
13.
HammermanKJPowellKEChristiansonCS. Pulmonary cryptococcosis: Clinical forms and treatment: A center for disease control cooperative mycoses study. Am Rev Respir Dis1973; 108: 1116–23.
14.
SchupbachCWWheelerCEBrigamanRAWarnerNAKanofEP. Cutaneous manifestation of disseminated cryptococcosis. Arch Dermatol1976;112:1734–40.
15.
CollinsVP. Bone involvement in cryptococcosis. Am J Roentgen1950;63:102–12.
16.
ZugerALouieEHolzmanRSSimberkoffMSRahalJJ. Cryptococcal disease in patients with AIDS. Ann Int Med1986;104:234–40.
17.
HolmbergKMeyerRD. Fungal infections in patients with AIDS and ARC. Scand J Infec Dis1986;18:179–92.
18.
KovacsJAKovacsAAPolisM, et al. Cryptococcosis in AIDS. Ann Int Med1985;103:533–8.
19.
FreemanGGWeidmanFD. Systemic blastomycosis of the cerebral gray matter caused by torula hystolytica. Arch Neurol Psychol1923;9:589–603.
LittmanMLZimmermanLE. Cryptococcosis. New York: Grune & Stratton, 1956: 8–37.
22.
BriggsDRBarneyPLBahuRM. Nasal cryptococcosis. Arch Otolaryngol Head Neck Surg1974;100:390–2.
23.
KohlmeierW. Turulose der nasennebenhoehlen nasal: Zentralblatt fur allgemeine pathologie und pathologische anatomie. Abl Allg Path Anat1955;93:92–3.
24.
MorganMAWilsonWRNeelHBIII.Fungal sinusitis in healthy and immune compromised individuals. AJCP1984;82:597–601.
25.
SarngadharanMGPopovicMBruchL, et al. Antibodies reactive with human T-lymphocytic retrovirus in the serum of patients with AIDS. Science1984;224:506–8.
26.
HoDDSarngadharanMGResnickL, et al. Primary human T-lymphotropic virus type III infection. Ann Intern Med1985;103:880–3.
27.
GoedertJJBiggarRJWeissSH, et al. Three-year incidence of AIDS in five cohorts of HTLV-III infected risk group members. Science1986;231:992–5.
28.
Centers for Disease Controls. Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. MMWR1984;34:373–5.
29.
WrightK. First tentative signs of therapeutic promise. Nature1986;323:383.